Figure 3.
Effects of compound 16b on the activities of 21 protein kinases in vitro. Protein kinases were of human origin and assayed in the presence of 1.0 μM compound 16b or vehicle (DMSO). The enzymatic activity was measured in the presence of Km ATP. Kinase activities were given as the mean of twice determinations. AMPKα1, AMP-activated protein kinase 1; AMPKα2, AMP-activated protein kinase 2; CDK4/cyclinD3, cyclin-dependent protein kinase-4/cyclinD3; CDK5/p35, cyclin-dependent protein kinase-5/p35; CHK1, checkpoint kinase-1; CK2, casein kinase-2; Lck, lymphocyte kinase; MSK1, mitogen- and stress-activated protein kinase-1; p70S6K, p70 ribosomal protein S6 kinase; PDK1, 3-phosphoinositide-dependent protein kinase-1; PKA, cAMP-dependent protein kinase; PKBα, protein kinase Bα; PKCα, protein kinase Cα; PRAK, p38-regulated/activated kinase; SAPK2a, stress-activated protein kinase-2a; SAPK2b, stress-activated protein kinase-2b; SAPK3, stress-activated protein kinase-3; SAPK4, stress-activated protein kinase-4; SGK, serum- and glucocorticoid-induced protein kinase.